|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
HSV, Type 1 and 2 DNA, QN Real Time PCR, Serum
Test Code16584
CPT Codes
87530 (x2)<br>Restricted Client Code
Preferred Specimen
1 mL CSF, vitreous, pericardial, pleural, or amniotic fluid collected in a sterile leak-proof container, or
1 mL frozen serum, or
1 mL plasma or whole blood collected in an EDTA (lavender-top) tube, or ACD (yellow-top) tube
1 mL frozen serum, or
1 mL plasma or whole blood collected in an EDTA (lavender-top) tube, or ACD (yellow-top) tube
Minimum Volume
0.3 mL
Other Acceptable Specimens
Bronchoalveolar lavage or bronchial wash collected in a sterile leak-proof container
Transport Container
Transport tube
Transport Temperature
CSF, vitreous, pericardial, pleural, or amniotic fluid: Frozen
Serum and plasma: Frozen
BAL or bronchial wash: Frozen
Whole blood: Refrigerated (cold packs)
Serum and plasma: Frozen
BAL or bronchial wash: Frozen
Whole blood: Refrigerated (cold packs)
Specimen Stability
Room temperature: 48 hours
Refrigerated: 7 days
Frozen: 30 days
Refrigerated: 7 days
Frozen: 30 days
Methodology
Real-Time PCR
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Set up: Daily; Report available: 1 day
Reference Range
HSV-1 DNA, QN PCR: Not detected
HSV-2 DNA, QN PCR: Not detected
HSV-2 DNA, QN PCR: Not detected
Clinical Significance
The detection of HSV-1 and HSV-2 DNA is based upon the real-time amplification, detection and differentiation of specific HSV-1 and HSV-2 genomic DNA sequences by PCR from total DNA extracted from the specimen. The quantitative range of this assay is 100 - 2,000,000 copies/mL.